Healthcare & Life Sciences
Zentalis Pharmaceuticals
United Stateszentalis.com
Zentalis Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
2014
Founded
1
Investors
About Zentalis Pharmaceuticals
Zentalis Pharmaceuticals is a startup founded in 2014 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company developing azenosertib, an investigational oral WEE1 kinase inhibitor, targeting ovarian and other cancers.
Explore Zentalis Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.